Recombinant Anti-C. difficile Toxins A/B VHH Single Domain Antibody (CAT#: NAB-2305-VHH)

1. Q 1: Can antibodies be employed against intracellular targets?

   A: Yes, but ensure proper permeabilization techniques to allow antibodies access to intracellular proteins.

2. Q 2: How is repeatability accomplished using antibodies?

   A: Standardize protocols, use consistent antibody lots, and maintain precise experimental conditions to ensure reproducibility.

3. Q 3: Are there any advantages to employing monoclonal antibodies over polyclonal antibodies in particular assays?

   A: Monoclonal antibodies provide specificity and uniformity, while polyclonals offer sensitivity due to multiple epitope recognition.

View the frequently asked questions answered by Creative Biolabs Support.